BIO says new JOBS bill could help start-ups

A provision in the new JOBS bill that Congress passed last week could be of particular benefit to biopharma companies by allowing them to spend more of their money on disease research, according to the Biotechnology Industry Organization (BIO).

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to Include the name and contact information (phone and email) for follow-up.